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INTRODUCTION
Cervical cancer is the leading causes of death in
gynecological cancers scope worldwide, which are
nearly half a million cases diagnosed each year.1,2
The current data estimated 493,243 women world-
wide diagnosed with cervical cancer each year;
while, 273,505 women died due to cervical cancer,
and approximately 90% of these new cases and
death was occurred in developing countries.3,4 In
Indonesia, based on data from 11 Pathology
departments across Indonesia in 2002, cervical
cancer was the top ten of most common cancers in
men and women which was contributed as 24%.5
In North Sulawesi, there were 1,615 women di-
agnosed with cervical cancer in 2013. Based on
registration data of patients in the Prof. dr. R.D.
Kandou hospital from January 2014 to July 2015,
there were 156 patients with cervical cancer who
were treated.6
According to the increase of life expectancy
around the world, especially for woman, it is es-
sential to know the survival rate in patients with
cervical cancer. Kim, et al. study in Korea in 2000
stated that through the 101-month follow up as
the median, the 5-year survival rate in 292 patients
diagnosed with stage Ib cervical cancer was 92%
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Objective: Determining the survival rate of early stage cervical can-
cer patients after radical hysterectomy.
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years old with a median of 45 years old. The largest proportion was
less than 50 years old (66.7%) and stage IIA cervical cancer (66.7%)
as the severity of cancer. Most histopathology type was the squa-
mous cell carcinoma (50.0%). About 70.8% patients did not have
lymph nodes metastasis and 62.5% patients did not receive adjuvant
therapy. This study revealed that 1-year, 2-year, 3-year, 4-year, and
5-year survival rate were 100.0%, 100.0%, 95.8%, 83.0%, 70.8%;
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Conclusion: The survival rate of early stage cervical cancer after
radical hysterectomy in Manado is quite high.
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Abstrak
Tujuan: Mengetahui kesintasan pasien kanker serviks stadium awal
yang dilakukan histerektomi radikal.
Metode: Penelitian ini menggunakan desain penelitian kohort re-
trospektif yang menganalisa 24 pasien kanker serviks stadium awalyang dilakukan histerektomi di RSUP Prof. dr. R.D. Kandou Manado
pada kurun waktu Januari 2008 hingga Desember 2010. Data yang
diperoleh diolah menggunakan analisis kesintasan Kaplan-Meier.
Hasil: Didapatkan rerata usia pasien adalah 47,75 tahun (rentang 33-63 tahun) dengan median 45 tahun. Proporsi terbanyak pada peneli-
tian ini adalah pasien dengan usia < 50 tahun (66,7%) dan pasien
kanker serviks stadium IIA (66,7%). Sebagian besar pasien memilikijenis histopatologi karsinoma sel skuamosa (50,0%). Pada 70,8%
pasien tidak terdapat penyebaran KGB dan 62,5% pasien tidak men-
dapatkan terapi adjuvan. Pada penelitian ini didapatkan kesintasan 1tahun sebesar 100,0%, 2 tahun sebesar 100,0%, 3 tahun sebesar
95,8%, 4 tahun sebesar 83,0% dan kesintasan keseluruhan 5 tahunadalah sebesar 70,8%.
Kesimpulan: Kesintasan pasien kanker serviks stadium awal pasca-histerektomi radikal di Manado secara keseluruhan cukup tinggi.
[Maj Obstet Ginekol Indones 2016; 4-3: 164-169]
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and in 74 patients with stage IIa cervical cancer
was 87%.7 Study held by Bulk, et al. in 2003 re-
ported that in Netherland, the 5-year survival rate
in 1,441 patients with cervical cancer was 71%.8
As well as the latest study in the United States by
Brookfield, et al. in 2008 depicted that the median
survival rate of the 5,367 cervical cancers was 43
months.9 Meanwhile, according to study by Sirait,
et al. in 1997, patients with cervical cancer in Dr.
Cipto Mangunkusumo hospital had 5-year survival
rate of 30% with a median survival of 213 patients
was 934 days (31 months).10
Clinical classification system for cervical cancer
by the International Federation of Gynecology and
Obstetrics (FIGO) is considered effective in predict-
ing the outcome of cervical cancer. Unfortunately,
we usually observe the poor prognosis in cervical
cancer patients with the same stage. To clarify this
disparity, many studies have tried to identify the
prognostic factors associated with cervical cancer.
Several factors, such as pelvic lymph node metas-
tasis, tumor size, depth of cervical stromal invasion,
hematogenous or lymphatic dissemination, histo-
pathologic type, and tumor extension to the corpus
uteri, vagina, parametrial limit the surgical resec-
tion which were related to the prognostic va-
lue.11,12 Therefore, this study aims to determine the
survival rate of early stage cervical cancer patients
after radical hysterectomy.
METHODS
The design of this study was a retrospective cohort
study with Kaplan-Meier survival analysis. This
study was conducted in Prof. dr. R.D. Kandou Hos-
pital, Manado from July to December 2015. The
population in this study were all patients with
early stage cervical cancer who had performed
radical hysterectomy in Prof. dr. R.D. Kandou
Hospital, Manado over the period of 1 January
2008 to 31 December 2010. 
We excluded the incomplete data on histopa-
thology in medical record, cervical cancer as not
the primary cancer, and unidentified medical re-
cords. The data were processed using Kaplan-
Meier survival analysis to look for overall 1-year,
2-year, 3-year, 4-year, and also 5-year survival rate.
RESULTS
Based on the medical records in Prof. dr. R.D. Kan-
dou hospital Manado and Pathology Department,
Faculty of Medicine Universitas Sam Ratulangi,
there were 24 patients recruited in this study. The
mean age of patients was 47.8 (33-63) years old
with the median of it was 45 years old. The highest
proportion of patients was below 50 years old
(66.7%) and stage II cervical cancer (66.7%). Most
patients had histopathologic type of squamous cell
carcinoma (50%). Of 70.8% patients, there were
no lymph node metastasis and 62.5% patients did
not receive adjuvant therapy.
The figure 1 described the analysis result of
using the Kaplan-Meier on 24 subjects. We found
that 1-year, 2-year, 3-year, 4-year, and 5-year
survival rate were 100%, 100.0%, 95.8%, 83.0%,
70.8%; respectively.
In addition, an analysis of the survival rate on
some prognostic factors, it was found that 5-year
survival rate of patients below 50 years old was
74.8% and the 5-year survival rate in stage II cer-
vical cancer patients was 62.3% (Figure 2). Mean-
while, the 5-year survival rate of patients living
with histopathological types of squamous cell car-
cinomas were 83.2% (Figure 3).
The 5-year survival rate of patients living with-
out lymph node metastasis was 94%, whereas the
5-year survival rate of patients who received adju-
vant therapy was 88.9% (Figure 4).
Figure 1. The 5-year Survival Rate of Early Stage Cervi-
cal Cancer Patients who had Performed Radical Hysterec-
tomy
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Figure 2.  The 5-year Survival Rate Based on Age Group (left) and Stage of Cervical Cancer (right)
Figure 4. The 5-year Survival Rate Based on Lymph Node Metastasis (left) and Adjuvant Therapy (right)
Figure 3. The 5-year Survival Rate Based on Histopathological Type
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DISCUSSION
In this study, we analyzed 24 cases of early stage
cervical cancer who had performed radical hyste-
rectomy in Prof. dr. R.D. Kandou Hospital Manado
on the period of 1 January 2008 to 31 December
2010. The occurrence of information bias in this
study was because the design of the study used a
retrospective cohort, in which all the relevant
events that had occurred at the commencement of
the study; for example, the inaccurate data of pa-
tients’ death remembered by family. Apart from
that, there were also several missing cases (loss to
follow up). We optimized the observation follow
up less than 5 years through several ways, such as
appropriate phone number listed in medical re-
cords or home visit. This primary data were ob-
tained from medical records; therefore, the incom-
plete data would affect the overall result.
Overall, of 24 women in this study, there were
7 patients (29.2%) died so that the survival rate
was 70.8%. In this study, there were 5 women
(20.8%) who regularly undertook the treatment at
the hospital for up to 5 years or until the patient
dies. Unfortunately, most patients did not have
good adherence to the treatment.
The survival rate of early stage cervical cancer
patients who had performed radical hysterectomy
showed the overall 1-year, 2-year, 3-year, 4-year,
and 5-year survival rate were 100.0%, 100.0%,
95.8%, 83.0%, and 70.8%. Actually, the 5-year sur-
vival rate in this study was lower than other stu-
dies conducted in some developed and developing
countries. The reasons for the difference in the sur-
vival rate are due to large number of patients who
lost to follow-up for 5 years and the divergence
among prognostic factors in every center.
In this study, the average age of patients was
47.75 years old with a median of 45 years old. This
result was in accordance with study conducted by
Ho, et al. They stated that the median age of pa-
tients with early stage cervical cancer was 47 years
old.1 Similarly, study held by Kim, et al. explained
that the mean age of patients with early stage cer-
vical cancer was 48.5 years old with a range of 22-
71 years old.7 Data from Canada also showed the
mean age of 49 years old with the median age of
46 years old.1
Based on previous studies, there were relation-
ship between age and survival rate of patients with
cervical cancer. However, this study revealed the
survival rate difference was found in both age
groups.
According to study by Rijker, et al., the 5-year
survival rate in patients with stage IB-IIA cervical
cancer was not significantly different between age
groups, but it had meaningful survival rate
difference in patients with advanced stage cervical
cancer.13
The results showed a tendency early stage cer-
vical cancer patients with age below 50 years old
had a 5-year survival higher than cervical cancer
patients with age above 50 years old. Indeed, the
study conducted by Tone Bjorge, et al. in Norway
on 7,429 women with cervical cancer concluded
that there was a tendency of worse prognosis in
patients with cervical cancer in young age.14
Atahan, et al. also got significant 5-year survival
rate differences (p = 0.001) in women with cervical
cancer aged less than 40 years old compared to
patients with cervical cancer at age more than 40
years old.15
In this study, patients with cervical cancer diag-
nosed with stage IA, IB, and IIA were 4 (16.7%), 4
(16.7%), and 16 (66.7%) patients; contributively.
Every region exhibited the various rates of it. Study
conducted in Korea showed that patients with sta-
ge IB was 79.8% and patients with stage IIA was
20.2% in 2000.7 Data from Taiwan in 2004 showed
that the number of patients with stage IB and IIA
were 81.7% and 18.3%.11 Meanwhile, according to
study by Chyong, et al. in 2007, the number of cer-
vical cancer patients stage IB and IIA were 88.1%
and 11.9%.16 This distinction may be due to the
differences in the number of samples and low co-
verage of Pap smear in Indonesia as an early de-
tection of cervical cancer.
The 5-year survival rate of cervical cancer pa-
tients with stage I and II in this study were 87.5%
and 62.2%; respectively. This finding was similar
to other studies.
In this study, the number of cases with his-
topathological type of squamous cell carcinoma
(SCC) were 12 patients (50.0%), adeno-squamous
carcinoma were 4 patients (16.7%) and adenocar-
cinoma were 8 patients (33.3%). The proportion
of the cases was opposite with several other stu-
dies. Based on the report by FIGO, the majority of
cervical cancers are squamous cell carcinoma types
histopathology (80%) followed by adenocarcino-
ma (11%) and adeno-squamous carcinoma (6%).
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Based on study in Taiwan on early stage cervical
cancer, they obtained the majority of cases were
squamous carcinoma (83.2%) and the remaining
were 16.8% of adenocarcinoma and adeno-squa-
mous carcinoma.16 This different distribution may
be caused by distinction in the number of samples
in this study and the risk factors according to dif-
ferent places and cultures; for example, the num-
ber of oral contraception which is used long term.
In this study, the 5-year survival rate of cervical
cancer patients with a histopathologic type of squa-
mous cell carcinoma was higher than other types
of histopathology. The study by Chen, et al. con-
cluded that the histopathologic type of adenocarci-
noma had worse survival rate in patients with
stage I and II after radical hysterectomy.17 The his-
topathological type of adeno-squamous carcinoma
showed lower survival rate than squamous cell
carcinoma in the early stage.18 According to FIGO,
this only applies significantly in stage IV, other than
the histopathologic type of squamous cell carcino-
ma and adenocarcinoma, it has worse survival,
yet.19 Contrary, study held by Look, et al. and Lee,
et al. did not get the difference in survival rate be-
tween squamous cell carcinoma and adenocarci-
noma.20,21 Reis, et al. in their study also concluded
that there was no evidence that the type of his-
topathology would affect the survival rate.22
In this study, the number of cases with lymph
node metastasis were 7 patients (29.2%) and the
number of cases without metastasis were 17 pa-
tients (70.8%). There were differences in survival
rate of the presence and absence of lymph nodes
metastasis in this study. These results were similar
to a lot of study that the most dependent variables
associated with survival rate was the status of
lymph node metastasis. Patients without lymph
node metastasis had 5-90% of survival rate,
whereas if there were positive lymph node metas-
tasis, the survival rate became 20-74% based on
lymph nodes metastasis location and size.12 Like-
wise, this study found the 5-year survival rate of
cervical cancer patients without lymph node me-
tastasis was 94% differed greatly in patients with
lymph node metastasis (14.4%).
In this study, a total of 9 patients with cervical
cancer (37.5%) received adjuvant therapy and 15
patients with cervical cancer (62.5%) cases did not
get the adjuvant therapy. Giving adjuvant chemora-
diation may improve survival rate up to 43 months
compared with patients with similar characteris-
tics who receiving radiotherapy adjuvant.12 Ac-
cording to the study by Lahousen, et al., adjuvant
chemotherapy or radiation did not improve sur-
vival rate or recurrence rate in patients with high
risk of cervical cancer after radical hysterectomy.23
In this study, the group of patients who received
adjuvant therapy had a 5-year survival rate of
88.9%; while, the group of patients who did not
get adjuvant therapy was around 60%.
CONCLUSION
The survival rate of early stage cervical cancer after
radical hysterectomy in Manado is quite high. Sev-
eral prognostic factors, such as age, stage of cervi-
cal cancer, the type of histopathology, lymph node
metastasis and adjuvant therapy affect 5- year sur-
vival rate of cervical cancer patients who perform-
ing radical hysterectomy.
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